Cormorant Asset Management, LP Diversified Active

CIK: 0001583977 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 14, 2018

Total Value ($000): $955,302 (100.0% shares, 0.0% debt)

Holdings (52)

ANAB ANAPTYSBIO INC 13.2%
Value ($000) $126,050 Shares 1,251,485 Est. Cost $34.01 Unrealized +116.4%
NEKTAR THERAPEUTICS 12.5%
Value ($000) $119,303 Shares 1,997,700 Est. Cost $59.72 Unrealized
APLS APELLIS PHARMACEUTICALS INC 8.6%
Value ($000) $81,782 Shares 3,768,757 Est. Cost $14.72 Unrealized 0.0%
NEKTAR THERAPEUTICS 4.7%
Value ($000) $44,790 Shares 750,000 Est. Cost $59.72 Unrealized
OMER OMEROS CORP 3.6%
Value ($000) $34,004 Shares 1,750,000 Est. Cost $17.26 Unrealized +8.6%
BLUEPRINT MEDICINES CORP 3.6%
Value ($000) $33,935 Shares 450,000 Est. Cost $67.43 Unrealized
MYOKARDIA INC 3.5%
Value ($000) $33,680 Shares 800,000 Est. Cost $17.38 Unrealized
DICERNA PHARMACEUTICALS INC 3.5%
Value ($000) $33,020 Shares 3,656,669 Est. Cost $9.03 Unrealized
IFRX INFLARX NV 3.2%
Value ($000) $30,130 Shares 1,438,207 Est. Cost $17.97 Unrealized 0.0%
JUNO THERAPEUTICS INC 2.6%
Value ($000) $25,141 Shares 550,000 Est. Cost $30.37 Unrealized
TBPH THERAVANCE BIOPHARMA INC 2.6%
Value ($000) $25,101 Shares 900,000 Est. Cost $23.62 Unrealized +25.3%
MIRATI THERAPEUTICS INC 2.4%
Value ($000) $22,475 Shares 1,231,522 Est. Cost $12.93 Unrealized
QUOTIENT LTD 2.3%
Value ($000) $22,216 Shares 4,488,121 Est. Cost $9.14 Unrealized
AVEXIS INC 2.3%
Value ($000) $22,134 Shares 200,000 Est. Cost $110.67 Unrealized
PROTEOSTASIS THERAPEUTICS IN 2.0%
Value ($000) $19,239 Shares 3,300,000 Est. Cost $12.20 Unrealized
ARGX ARGENX SE 1.9%
Value ($000) $18,311 Shares 290,000 Est. Cost $63.14 Unrealized
QTRX QUANTERIX CORP 1.9%
Value ($000) $18,202 Shares 847,789 Est. Cost $19.52 Unrealized 0.0%
G1 THERAPEUTICS INC 1.9%
Value ($000) $17,806 Shares 897,505 Est. Cost $20.91 Unrealized
OMER OMEROS CORP 1.8%
Value ($000) $17,001 Shares 875,000 Est. Cost $17.26 Unrealized +8.6%
NBIX NEUROCRINE BIOSCIENCES INC 1.6%
Value ($000) $15,518 Shares 200,000 Est. Cost $15.30 Unrealized +345.9%
BLUEBIRD BIO INC 1.5%
Value ($000) $14,248 Shares 80,000 Est. Cost $105.05 Unrealized
ANAB ANAPTYSBIO INC 1.4%
Value ($000) $13,597 Shares 135,000 Est. Cost $34.01 Unrealized +116.4%
CLEARSIDE BIOMEDICAL INC 1.4%
Value ($000) $13,586 Shares 1,940,880 Est. Cost $7.30 Unrealized
ACRS ACLARIS THERAPEUTICS INC 1.4%
Value ($000) $13,563 Shares 550,000 Est. Cost $19.94 Unrealized +22.1%
ASND ASCENDIS PHARMA A S 1.3%
Value ($000) $12,018 Shares 300,000 Est. Cost $40.06 Unrealized
AUDENTES THERAPEUTICS INC 1.1%
Value ($000) $10,559 Shares 337,876 Est. Cost $18.38 Unrealized
ABEONA THERAPEUTICS INC 1.0%
Value ($000) $9,114 Shares 575,000 Est. Cost $8.20 Unrealized
ARRAY BIOPHARMA INC 0.9%
Value ($000) $8,960 Shares 700,000 Est. Cost $6.75 Unrealized
PTGX PROTAGONIST THERAPEUTICS INC 0.9%
Value ($000) $8,320 Shares 400,000 Est. Cost $13.67 Unrealized +29.8%
BIOHAVEN PHARMACTL HLDG CO L 0.8%
Value ($000) $8,035 Shares 297,803 Est. Cost $26.98 Unrealized
WVE WAVE LIFE SCIENCES LTD 0.7%
Value ($000) $7,093 Shares 202,079 Est. Cost $17.46 Unrealized +67.0%
ZLAB ZAI LAB LTD 0.7%
Value ($000) $7,073 Shares 333,166 Est. Cost $27.00 Unrealized
SGMO SANGAMO THERAPEUTICS INC 0.7%
Value ($000) $6,560 Shares 400,000 Est. Cost $6.37 Unrealized +133.4%
GEMPHIRE THERAPEUTICS INC 0.7%
Value ($000) $6,360 Shares 800,000 Est. Cost $10.90 Unrealized
REATA PHARMACEUTICALS INC 0.6%
Value ($000) $5,664 Shares 200,000 Est. Cost $31.10 Unrealized
COLL COLLEGIUM PHARMACEUTICAL INC 0.6%
Value ($000) $5,538 Shares 300,000 Est. Cost $17.28 Unrealized -17.1%
MERSANA THERAPEUTICS INC 0.5%
Value ($000) $4,856 Shares 295,548 Est. Cost $16.39 Unrealized
JOUNCE THERAPEUTICS INC 0.5%
Value ($000) $4,682 Shares 367,223 Est. Cost $21.80 Unrealized
TRILLIUM THERAPEUTICS INC 0.5%
Value ($000) $4,380 Shares 600,000 Est. Cost $4.40 Unrealized
INTEC PHARMA LTD JERUSALEM 0.4%
Value ($000) $4,170 Shares 809,804 Est. Cost $5.59 Unrealized
MARINUS PHARMACEUTICALS INC 0.4%
Value ($000) $4,080 Shares 500,000 Est. Cost $8.16 Unrealized
ARDX ARDELYX INC 0.4%
Value ($000) $3,780 Shares 572,738 Est. Cost $15.57 Unrealized -61.9%
MINERVA NEUROSCIENCES INC 0.4%
Value ($000) $3,678 Shares 607,903 Est. Cost $7.26 Unrealized
HRTX HERON THERAPEUTICS INC 0.4%
Value ($000) $3,620 Shares 200,000 Est. Cost $15.72 Unrealized +3.7%
CONTRAFECT CORP 0.4%
Value ($000) $3,586 Shares 3,550,000 Est. Cost $2.80 Unrealized
ACCELERON PHARMA INC 0.3%
Value ($000) $3,183 Shares 75,000 Est. Cost $32.04 Unrealized
SYROS PHARMACEUTICALS INC 0.3%
Value ($000) $2,883 Shares 296,296 Est. Cost $16.09 Unrealized
OVID OVID THERAPEUTICS INC 0.2%
Value ($000) $2,211 Shares 223,972 Est. Cost $13.06 Unrealized -29.7%
ONCOBIOLOGICS INC 0.0%
Value ($000) $40 Shares 30,536 Est. Cost $3.28 Unrealized
ONCOBIOLOGICS INC 0.0%
Value ($000) $13 Shares 416,666 Est. Cost $0.46 Unrealized
ONCOBIOLOGICS INC 0.0%
Value ($000) $9 Shares 416,666 Est. Cost $0.45 Unrealized
CELLECTAR BIOSCIENCES INC 0.0%
Value ($000) $5 Shares 52,999 Est. Cost $0.55 Unrealized